PT  - JOURNAL ARTICLE
AU  - Jacobson, Anne
ED  - Chaturvedi, Nishi
TI  - Candesartan Reverses Retinopathy in Type 2 Diabetes
DP  - 2008 Nov 01
TA  - MD Conference Express
PG  - 15--16
VI  - 8
IP  - 7
4099  - http://mdc.sagepub.com/content/8/7/15.short
4100  - http://mdc.sagepub.com/content/8/7/15.full
AB  - Candesartan may have a place in the treatment of retinopathy in patients with type 1 or 2 diabetes, according to findings from the Diabetic Retinopathy Candesartan Trials (DIRECT) study program. The DIRECT-Protect 1 and 2 trials are the first to show the potential benefits of angiotensin-II receptor blockers in patients with baseline diabetic retinopathy.